Wednesday reads to get your day going the right way.
- The (new) top 10 pharma companies by 2017 revenue
- Will New Study Cut Guesswork for Depression Medicine Prescriptions?
- Banks scramble to assemble Asian biotech IPO resources. Institutions aim to capitalize on a listings boom but lack expertise in the region.
- A stealthy Harvard startup wants to reverse aging in dogs, and humans could be next
MattCorc 